Intratracheal and subcutaneous liposomal VIP normalizes arterial pressure in spontaneously hypertensive hamsters

International Journal of Pharmaceutics

Volumn 316, Issue 1-2, 2006, Pages 144-147

  Rubinstein, Israel ^a,c   Ikezaki, Hiroyuki ^a,c   Önyüksel, Hayat ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Drug delivery; DSPE PEG; Formulation; Sterically stabilized liposomes

Indexed keywords

BIOMATERIAL; LIPOSOME; PEPTIDE; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; HAMSTER; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CRICETINAE; HYPERTENSION; INJECTIONS, SUBCUTANEOUS; INTUBATION, INTRATRACHEAL; LIPOSOMES; MALE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33646802288     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.02.028     Document Type: Article

References (5)

1. Cosentino F., and Volpe M. Hypertension, stroke, and endothelium. Curr. Hypertens. Res. 7 (2005) 68-71
2. Gololobov G., Noda Y., Sherman S., Rubinstein I., Baranowska-Kortylewicz J., and Paul S. Stabilization of vasoactive intestinal peptide by lipids. J. Pharmacol. Exp. Ther. 285 (1998) 753-758
3. Henning R.J., and Sawmiller D.R. Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc. Res. 49 (2001) 27-37
4. Séjourné F., Rubinstein I., Suzuki H., and Alkan-Önyüksel H. Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes. Pharm. Res. 14 (1997) 362-365
5. Suzuki H., Noda Y., Gao X.-p., Séjourné F., Alkan-Önyüksel H., Paul P., and Rubinstein I. Encapsulation of vasoactive intestinal peptide into liposomes restores vasorelaxation in hypertension in situ. Am. J. Physiol. 271 (1996) H282-H287